2-aminothiazole has been researched along with Glioblastoma in 1 studies
2-aminothiazole: RN given refers to parent cpd; structure
1,3-thiazol-2-amine : A primary amino compound that is 1,3-thiazole substituted by an amino group at position 2.
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hedna, R | 1 |
| DiMaio, A | 1 |
| Robin, M | 1 |
| Allegro, D | 1 |
| Tatoni, M | 1 |
| Peyrot, V | 1 |
| Barbier, P | 1 |
| Kovacic, H | 1 |
| Breuzard, G | 1 |
1 other study available for 2-aminothiazole and Glioblastoma
| Article | Year |
|---|---|
2-Aminothiazole-Flavonoid Hybrid Derivatives Binding to Tau Protein and Responsible for Antitumor Activity in Glioblastoma.
Topics: Glioblastoma; Humans; Microtubules; Protein Binding; tau Proteins; Thiazoles; Tubulin | 2023 |